Medicure Inc. (TSXV:MPH)
4.300
-0.100 (-2.27%)
Oct 30, 2026, 3:49 PM EDT
Medicure Revenue
Medicure had revenue of 7.43M CAD in the quarter ending June 30, 2026, with 11.37% growth. This brings the company's total for the last twelve months to 32.08M, up 38.25% year-over-year. In the year 2025, Medicure had annual revenue of 28.86M with 31.72% growth. That makes Medicure the 32,986th largest company in the world by revenue and 596th in Canada.
Revenue (ttm)
32.08M
Revenue Growth
+38.25%
P/S Ratio
1.43
Revenue / Employee
844.11K
Employees
38
Market Cap
44.88M
Revenue by Segment
- Retail and Mail Order Pharmacy 20.29M 70.3%
- Marketing and Distribution of Commercial Products 8.57M 29.7%
Fiscal year ended Dec 31, 2025 See the full Medicure breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.86M | 6.95M | 31.72% |
| Dec 31, 2024 | 21.91M | 213.00K | 0.98% |
| Dec 31, 2023 | 21.69M | -1.37M | -5.94% |
| Dec 31, 2022 | 23.07M | 1.32M | 6.08% |
| Dec 31, 2021 | 21.74M | 10.13M | 87.29% |
| Dec 31, 2020 | 11.61M | -8.56M | -42.45% |
| Dec 31, 2019 | 20.17M | -8.94M | -30.70% |
| Dec 31, 2018 | 29.11M | 1.98M | 7.28% |
| Dec 31, 2017 | 27.13M | -2.17M | -7.41% |
| Dec 31, 2016 | 29.30M | 7.22M | 32.70% |
| Dec 31, 2015 | 22.08M | 17.03M | 337.22% |
| May 31, 2014 | 5.05M | 2.45M | 94.06% |
| May 31, 2013 | 2.60M | -2.19M | -45.74% |
| May 31, 2012 | 4.80M | 1.17M | 32.21% |
| May 31, 2011 | 3.63M | 311.20K | 9.38% |
| May 31, 2010 | 3.32M | -1.48M | -30.79% |
| May 31, 2009 | 4.79M | 2.55M | 113.27% |
| May 31, 2008 | 2.25M | -3.70M | -62.20% |
| May 31, 2007 | 5.94M | - | - |
| May 31, 2006 | - | - | - |
| May 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| iAnthus Capital Holdings | 197.59M |
| Planet 13 Holdings | 131.28M |
| Decibel Cannabis Company | 127.08M |
| Vext Science | 71.97M |
| Rubicon Organics | 64.23M |
| Leef Brands | 47.36M |
| LSL Pharma Group | 41.83M |
| ZYUS Life Sciences | 374.00K |
Medicure News
- 4 weeks ago - Medicure Announces Grant of Stock Options - Accesswire
- 4 weeks ago - Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial - Accesswire
- 7 weeks ago - Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress - Accesswire
- 2 months ago - Medicure Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Medicure Report: Q2 2026 - Filings
- 2 months ago - Medicure MD&A: Q2 2026 - Filings
- 2 months ago - Medicure Earnings release: Q2 2026 - Filings
- 2 months ago - Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call - Accesswire